Skip Navigation

Top 3 Areas Where CostCheck™ Customers Are Seeing the Most Savings.

Blog

Top 3 Areas Where CostCheck™ Customers Are Seeing the Most Savings.

Top 3 Areas Where CostCheck™ Customers Are Seeing the Most Savings. By Hannah Kanfer BluesightⓇ …

Blog

What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital?

What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital? By: Sandy Still, PharmD…

Blog

Drug Shortages, Variance Spikes and Other Key Takeaways from the Diversion Quarterly.

By Hannah Kanfer   BluesightⓇ released the Q2 2022 Diversion Quarterly, sharing data from its…

Blog

Why a Next-Generation Drug Diversion Solution is Vital for Hospitals.

By: Doug Zurawski, Pharm.D.   Drug diversion is any act or deviation that removes a…

Blog

The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report

Kit Check recently released its 2022 Diversion Trends Report. In the report, Kit Check analyzed…

Blog

KitCheck™ Releases New Medication Pricing Information Function as First Step Towards Further Product Integration.

By Hannah Kanfer KitCheck recently released a new feature that integrates medication pricing information into…

Blog

BluesightⓇ Partners with Fagron to Expand the Availability of Pre-Tagged Medication

By Hannah Kanfer Recently, Bluesight announced its partnership with Fagron in launching RFID tagged, ready-to…

Blog

New Bill Will Help Prevent Opioid Deaths by Making Opioid Overdose Medications More Accessible. 

By Hannah Kanfer   The opioid epidemic has been a long battle in the United…

Blog

Children’s Hospitals Face Unique Challenges When It Comes to Drug Diversion.

Recently, the Bluesight Community hosted a panel of pharmacy leaders from children’s hospitals to discuss…

Blog

ControlCheck™ Releases New Update to Include Auditing for Medical Supplies.

By Hannah Kanfer   ControlCheck released an update that supports closed-loop reconciliation for medical supplies….

3 of 18